Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Trends and Finance
Cue Health to cease operations, lay off all employees
Following a series of layoffs and a warning from the U.S. Food and Drug Administration to discontinue use of its COVID-19 diagnostic test, Cue Health will shut down its operations and lay off its remaining staff this week.
Featured
Molecular Diagnostics
Molecular testing studied for remote post-transplant care
Gene silencing and gene editing
New approach may improve CRISPR safety, accuracy
Latest News
Amgen gets FDA approval for small cell lung cancer therapy
May 17, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Backlog of unresolved medical diagnoses leads to new method for clinical exome reanalysis
May 16, 2024
T2 Biosystems to sell $8M in stock in private placement
May 16, 2024
Business Insights
Trends and Finance
Cue Health to cease operations, lay off all employees
Research and Development
Novel oncology tests capture large share of new PLA codes effective July 1
Business Insights
New additions to Orchard Software
Lawsuit
U.K. Patents Court orders Advanced Cell Diagnostics to pay Molecular Instruments, revokes patents
Diagnostic Technologies
Lawsuit
U.K. Patents Court orders Advanced Cell Diagnostics to pay Molecular Instruments, revokes patents
Molecular Diagnostics
Molecular testing studied for remote post-transplant care
Gene silencing and gene editing
New approach may improve CRISPR safety, accuracy
Regulatory Approval
Karius gets FDA breakthrough device designation for infectious disease test
Diseases
Research and Development
Novel oncology tests capture large share of new PLA codes effective July 1
Sbir Grant
Nanopath awarded $4M in SBIR grants
Molecular Diagnostics
Molecular testing studied for remote post-transplant care
Research and Development
Biogen bets $1.15B on HI-Bio's autoimmune kidney disease drug
More from LabPulse.com
GMU researchers receive $1.2M in funding for Lyme disease urine test
By
LabPulse.com staff writers
Researchers at George Mason University (GMU) have received $1.2 million in federal funding from the U.S. Department of the Army to develop a urine-based test for the detection and diagnosis of Lyme disease.
May 24, 2024
Novel oncology tests capture large share of new PLA codes effective July 1
By
LabPulse.com staff writers
Deadline for next Clinical Laboratory Fee Schedule (CLFS) annual meeting in June is May 30.
May 23, 2024
Nanopath awarded $4M in SBIR grants
By
LabPulse.com staff writers
Nanopath has announced that it has been awarded two grants worth a total of $4 million in federal funding through the Small Business Innovation Research (SBIR) program.
May 22, 2024
New additions to Orchard Software
By
LabPulse.com staff writers
Digital pathology, molecular testing, antimicrobial use and resistance (AUR) reporting
May 24, 2024
U.K. Patents Court orders Advanced Cell Diagnostics to pay Molecular Instruments, revokes patents
By
LabPulse.com staff writers
The Patents Court of the High Court of England and Wales has ordered that two patents owned by Bio-Techne brand Advanced Cell Diagnostics be revoked and has dismissed ACD's infringement claims against Molecular Instruments.
May 23, 2024
Biogen bets $1.15B on HI-Bio's autoimmune kidney disease drug
By
LabPulse.com staff writers
The therapy could ultimately improve clinical outcomes in a broad range of immune-mediated diseases, according to Biogen.
May 22, 2024
Oxford Nanopore integrates Twist technology for long-read sequencing
By
LabPulse.com staff writers
The newly unveiled Twist-Oxford Nanopore long-read PGx solution is available for research use only.
May 22, 2024
Karius gets FDA breakthrough device designation for infectious disease test
By
LabPulse.com staff writers
Karius announced today that its Karius Test for the diagnosis and management of lung infections in immunocompromised patients has been granted breakthrough device designation from the FDA.
May 16, 2024
Clinical lab to pay $2.5M for rent sham kickback scheme
By
LabPulse.com staff writers
The lab's agreements with physician practices and providers typically provided for the use of an exam room by lab personnel, as well as for the use of basic equipment.
May 17, 2024
BioMarin confirms layoffs and R&D cuts
By
LabPulse.com staff writers
Roctavian, BioMarin's gene therapy for severe hemophilia A, generated $800,000 in net product revenue in the first quarter of 2024.
May 15, 2024
FDA issues warning for Cue Health COVID-19 tests
By
LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) issued a warning to consumers and healthcare providers not to use Cue Health's COVID-19 over-the-counter test and its COVID-19 test intended for point-of-care settings due to an increased risk of false results.
May 14, 2024
Biomarker extraction through ultrasound shows promise for cancer detection
By
LabPulse.com staff writers
Ultrasound can be used to extract biomarkers from cells for less-invasive cancer detection, new research findings show.
May 13, 2024